Registered Number
:
13431491
|
For the period ended 30 June 2022
England and Wales
Unaudited Financial Statements
For the period ended 30 June 2022
Cerberus Method Ltd
Contents Page
1
Statement of Financial Position and Notes to the Accounts
Cerberus Method Ltd
Statement of Financial Position and Notes to the Accounts
2022
243
Creditors
:
amounts falling due
|
(2,593)
(2,350)
Net current liabilities
Total assets less current liabilities
|
(2,350)
(2,350)
Net liabilities
(2,350)
Statutory Information
Cerberus Method Ltd is a private limited company
,
limited by shares
,
domiciled in England and Wales
,
registration
|
number
13431491
.
|
1A Patteson Road
Norwich
England
NR3 3EN
The presentation currency is £ sterling
.
|
1
.
Average number of persons employed
|
During the year the average number of employees was 2
For the period ended 30 June 2022 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
|
The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2022 in accordance with Section 476 of the Companies Act 2006.
|
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
|
b
)
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
|
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
|
394
and
395
and which otherwise comply with the requirements of the Companies Act
2006
relating to financial
|
statements
,
so far as applicable to the company
.
|
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
|
Mr Milton Dos Santos Sequeira Director
|
These financial statements were approved and authorised for issue by the Board on 26 February 2023 and were signed by:
|
1 of 1